What is the role of pharmacologic vasoconstrictors in local anesthesia?

• A. To accelerate healing of tissues after surgery.
• B. To prolong anesthetic duration, reduce systemic absorption, and decrease intraoperative bleeding.
• C. To increase systemic absorption for faster onset.
• D. To cause vasodilation and increased bleeding.

Answer: (B)

The main idea is that pharmacologic vasoconstrictors constrict local blood vessels, which keeps the anesthetic at the injection site longer and reduces how quickly it enters the bloodstream. This combination prolongs the numbness by slowing local clearance, lowers the risk of systemic toxicity by reducing systemic absorption, and helps control bleeding during the procedure by narrowing blood vessels at the site. So, the best description includes all three effects: longer duration of anesthesia, less systemic absorption, and less intraoperative bleeding. The other options describe effects that aren’t produced by vasoconstrictors—vasodilation or increased bleeding, or ideas like faster onset through higher absorption—so they don’t fit the role of these agents.